These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 20564841)

  • 41. Dabigatran etexilate: a possible replacement for heparinoids and vitamin K antagonists?
    Guay DR
    Hosp Pract (1995); 2011 Feb; 39(1):105-25. PubMed ID: 21441766
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Role of orally available antagonists of factor Xa in the treatment and prevention of thromboembolic disease: focus on rivaroxaban.
    Morell J; Sullivan B; Khalabuda M; McBride BF
    J Clin Pharmacol; 2010 Sep; 50(9):986-1000. PubMed ID: 20124518
    [TBL] [Abstract][Full Text] [Related]  

  • 43. A review of oral anticoagulants in patients with atrial fibrillation.
    Greenspon AJ
    Postgrad Med; 2012 Nov; 124(6):7-16. PubMed ID: 23322134
    [TBL] [Abstract][Full Text] [Related]  

  • 44. An indirect comparison, via enoxaparin, of rivaroxaban with dabigatran in the prevention of venous thromboembolism after hip or knee replacement.
    Lereun C; Wells P; Diamantopoulos A; Rasul F; Lees M; Sengupta N
    J Med Econ; 2011; 14(2):238-44. PubMed ID: 21385145
    [TBL] [Abstract][Full Text] [Related]  

  • 45. New oral anticoagulants and their implications for dental patients.
    O'Connell JE; Stassen LF
    J Ir Dent Assoc; 2014; 60(3):137-43. PubMed ID: 25080640
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [New oral anticoagulants for atrial fibrillation: a neurologist's view].
    van Dijk EJ; Koudstaal PJ; Roos YB; Brouwers PJ; Kappelle LJ
    Ned Tijdschr Geneeskd; 2012; 156(39):A5283. PubMed ID: 23009824
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Current and future prospects for anticoagulant therapy: inhibitors of factor Xa and factor IIa.
    Harenberg J; Wehling M
    Semin Thromb Hemost; 2008 Feb; 34(1):39-57. PubMed ID: 18393142
    [TBL] [Abstract][Full Text] [Related]  

  • 48. New oral anticoagulants in development: potential for improved safety profiles.
    Bauer KA
    Rev Neurol Dis; 2010; 7(1):1-8. PubMed ID: 20410856
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [New anticoagulants: dabigatran, rivaroxaban and apixaban].
    Vargas Ruiz AG; Ramírez López AN; Medina Viramontes ME
    Gac Med Mex; 2012; 148(3):257-64. PubMed ID: 22820359
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Dabigatran etexilate in clinical practice: confronting challenges to improve safety and effectiveness.
    Gulseth MP; Wittkowsky AK; Fanikos J; Spinler SA; Dager WE; Nutescu EA
    Pharmacotherapy; 2011 Dec; 31(12):1232-49. PubMed ID: 22122184
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Efficacy and safety of dabigatran etexilate for the prevention of venous thromboembolism following total hip or knee arthroplasty. A meta-analysis.
    Wolowacz SE; Roskell NS; Plumb JM; Caprini JA; Eriksson BI
    Thromb Haemost; 2009 Jan; 101(1):77-85. PubMed ID: 19132192
    [TBL] [Abstract][Full Text] [Related]  

  • 52. New agents for orthopaedic thromboprophylaxis: caution essential, but time will tell.
    Verma AK
    ANZ J Surg; 2009 Nov; 79(11):773-4. PubMed ID: 20078521
    [No Abstract]   [Full Text] [Related]  

  • 53. [Novel anticoagulants for stroke prevention in atrial fibrillation].
    Baumhäkel M; Schirmer SH; Böhm M
    Dtsch Med Wochenschr; 2010 Nov; 135(46):2304-8. PubMed ID: 21064013
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Treatment of venous thromboembolism with dabigatran.
    Schulman S
    Curr Opin Pulm Med; 2012 Sep; 18(5):410-5. PubMed ID: 22617811
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Novel anticoagulants: new evidence for emerging drugs and their potential application in major lower limb surgery.
    Nikolaou VS; Harwood PJ; Karadimas EJ; Tan HB; Giannoudis PV
    Curr Vasc Pharmacol; 2011 Jan; 9(1):54-60. PubMed ID: 21044021
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Novel oral anticoagulants for stroke prevention in patients with atrial fibrillation: dawn of a new era.
    Contractor T; Levin V; Martinez MW; Marchlinski FE
    Postgrad Med; 2013 Jan; 125(1):34-44. PubMed ID: 23391669
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Clot prevention--common questions about medications.
    Tadros R; Shakib S
    Aust Fam Physician; 2010 Jul; 39(7):480-3. PubMed ID: 20628661
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Advances in anticoagulation: focus on dabigatran, an oral direct thrombin inhibitor.
    Augoustides JG
    J Cardiothorac Vasc Anesth; 2011 Dec; 25(6):1208-12. PubMed ID: 21982327
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The top 4 advances in antithrombotic care in the last year.
    Turpie AG
    Thromb Res; 2008; 123 Suppl 1():S2-6. PubMed ID: 18834617
    [TBL] [Abstract][Full Text] [Related]  

  • 60. What can ongoing clinical trials of anticoagulants demonstrate?
    Halperin JL
    J Cardiovasc Med (Hagerstown); 2009 Aug; 10(8):610-5. PubMed ID: 19553827
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.